Practice Connect #116

15 April 2021

Welcome to Practice Connect, a fortnightly update for practice managers, nurses and practice administration staff on relevant issues, upcoming events and education.

Read all stories



COVID-19 Vaccine Update

Last week, following advice issued by the Australian Technical Advisory Group on Immunisation (ATAGI), the national COVID-19 vaccination rollout will be revised in light of concerns about AstraZeneca’s COVID-19 vaccine’s possible links to an extremely rare clotting disorder.
The current advice from ATAGI states:

  •  ATAGI have recommended that Comirnaty (Pfizer) is the preferred COVID-19 vaccine for adults under 50 years of age.
  • The COVID-19 Vaccine AstraZeneca can be used in adults aged under 50 years where the benefits clearly outweigh the risk for that individual and the person has made an informed decision based on an understanding of the risks and benefits.
  • People who have had the first dose of COVID-19 Vaccine AstraZeneca without any serious adverse effects can be given the second dose, including adults under 50 years.

Read the full ATAGI advice here.
Both ATAGI and the Therapeutic Goods Administration (TGA) will continue to monitor the situation closely and WA Primary Health Alliance will provide practices with new information as soon as it comes to hand. 
The latest figures from Week 7 of the Australian Government COVID-19 reveal over one million COVID-19 vaccine doses have been administered in Australia (1,178,302), nearly half a million (473,578) of those administered in primary care.

In WA, over 15,000 doses (15,839) have been rolled out in aged care and disability settings and close to 40,000 (39,787) doses have been administered through primary care (general practice, GP respiratory clinics and Aboriginal Community Controlled Health Services).
This represents an estimated 82 percent utilisation of WA’s available COVID-19 doses (the third highest utilisation rate in the country after TAS and the ACT).  
Read more the latest Commonwealth update (12 April 2021) here.



WA thrombosis with thrombocytopenia (TTS) case linked to AstraZeneca COVID-19 vaccine

The Therapeutic Goods Association confirmed on the 13 April there had been a second case of TTS after a woman received the AstraZeneca COVID-19 vaccine.
The case occurred in a WA woman in her 40s who is now in a stable condition in hospital.
There have been about 700,000 doses of AstraZeneca given in Australia – meaning there has been a thrombosis event for every one in 350,000 doses.
Read the full update from the TGA here.

Thrombosis – what to look for

Providers should be aware of the warning signs In the rare case of a central venous sinus thrombosis (CVST) developing.
Reported cases of CVST following the AstraZeneca vaccine developed between four to 20 days after vaccination.
In some cases, the symptoms included a persistent headache that did not settle with analgesia, included features of raised intracranial pressure (including headache, confusion and vomiting, neurological deficits and/or seizures.
For more advice read ATAGI’s summary of current recommendations here.

Implications for the vaccine rollout after revised ATAGI advice

The Australian Government is working through these implications with the states and territories as an urgent priority.
The AstraZeneca vaccine remains highly effective at preventing death and severe illness among people who have contracted COVID-19 and the incidence of the blood-clotting syndrome is very rare.
The programme will be considered and recalibrated to take into account the ATAGI recommendations, with further updates provided as decisions are made.

Pfizer announcement and vaccine contracts

Australia has secured an additional 20 million doses of the Pfizer vaccine, bringing to 40 million the total number of Pfizer vaccines available this year to vaccinate the Australian population, thus reducing reliance on the AstraZeneca vaccine.

Additionally, Australia now has contracts for more than 170 million vaccines.
Investment in the portfolio of vaccines is based on advice from the expert Science and Industry Technical Advisory Group, which is continually monitoring and assessing each of the vaccines to ensure that Australia remains well prepared for the rollout when the regulatory health and safety approvals have been granted.

COVID-19 vaccinations for DVA clients

  • Arrangements for administering the COVID-19 vaccine to Department of Veterans’ Affairs (DVA) clients are the same as for the general public. This includes arrangements for billing through the Medical Benefits Schedule (MBS). For Medicare-eligible DVA clients, general practices should use the same MBS item numbers used for the general public. DVA clients can therefore use their Veteran Card as per usual DVA arrangements.
  • More detailed information for providers is available on the FAQ page on the Department of Health website. 

Women and pregnancy

ATAGI is currently reviewing their clinical advice and guidance for health professionals and consumers.
  • Clinical trials for new medicines do not typically include pregnant or breastfeeding participants.
  • In preparation for vaccine rollout, the Australian Technical Advisory Group on Immunisation (ATAGI) has developed clinical advice for health care providers on the use of COVID-19 vaccines in Australia in 2021 available online

Resources published on the Department of Health website have been updated

The National Centre for Immunisation for Research and Surveillance (NCIRS) is continuing to update further resources and we will provide further updates and these links as soon as they are available.

In the context of the national picture as of 28 March, WA’s progress was impressive and we continue to work closely with the Commonwealth government’s vaccine workforce provider, to maintain and improve systems and processes.



COVID-19 HealthPathways Updates

The following content updates have now been published on the HealthPathways site:


COVID-19 Vaccination Information 
Updated resources including:
  • Provider guide for obtaining informed consent
  • Consent form for COVID-19 vaccination
  • Consumer information on the AstraZeneca vaccine
  • Information for after your AstraZeneca vaccine.

COVID-19 Vaccination Procedure

  • Updated information to “CE note” and “Follow up" section based on updated ATAGI statement (2nd April) on specific clotting conditions being reported after COVID-19 vaccination and on ATAGI‘s recommendations for the investigation and management of patients who may present with symptoms suggestive of thrombosis associated with thrombocytopenia 4-20 days following AstraZeneca vaccination.
  • Added ATAGI statement for consumers on this rare clotting condition.
  • Added quick link to Australian Department of Health - Priority Groups for COVID-19 Vaccination Program: Phase 1b for information on eligibility, specifics on underlying medical conditions, proof of eligibility and proof of vaccination.
COVID-19 Telehealth:
Updated to reflect the extension of:
  • Temporary MBS telehealth and phone consultation services until 30 June 2021
  • Use of a digital image of a legal paper prescription until 30 September 2021.

COVID-19 MBS items:
Updated to reflect the extension of the temporary MBS telehealth and phone consultation services until 30 June 2021.

To access HealthPathways please email the HealthPathways team at




Stay up to date with COVID-19 Vaccine Developments

COVID-19 Vaccination Training Modules - Update
Please see the following notice regarding the COVID-19 Vaccination Training Modules:

  • Significant updates have occurred in to the COVID-19 vaccination training program on Friday 9 April.
  • Module progress and completion have not been affected.
  • You are expected to login and view the new information.
  • A summary of the updates can be found in the announcement forum.
  • All changes within the modules are identified by 'NEW' in red.
AstraZeneca excess dose policy
The Australian Government Department of Health has published information on AstraZeneca excess doses. This AstraZeneca excess dose policy is for general practice, including GP Respiratory Clinics and Aboriginal Community Controlled Health Services
Excess doses are those doses of COVID-19 vaccine which will expire before the next scheduled vaccination clinic/patients booked for COVID-19 vaccine.
Please note that storage advice differs for AstraZeneca vaccine depending on whether it has been pre-drawn into a syringe or remains in the vial.
Where possible practices should aim to minimise excess doses. This can be through batching bookings within a vaccination session to match the number of doses available in a vial.
However, sometimes excess doses will remain at the end of a session, and these doses might expire before the next session is scheduled. For example, this could happen because of cancelled appointments or no shows.
In this case, it is recommended that clinics use the following strategies to prioritise others for vaccination in order to minimise vaccine wastage:
  • Maintain a reserve list of eligible patients. These may be patients who have not been able to secure a vaccine appointment or have booked later but could come in at short notice. (Note: If a vial is opened but refrigerated, then the vaccine can still be administered up to 48 hours post opening. Clinics may identify and vaccinate eligible patients within that timeframe, regardless of when they have booked their next vaccination clinic.)
  • Use identified excess doses for other patients or staff who fit the eligibility criteria and who are present in the practice.
Where these options are not available, practices should use identified excess doses for other patients or staff who fit the 2A or 2B eligibility criteria. This could include those present around the practice when excess doses are identified, such as those working in other businesses in the same building.
Practices should note and plan for people receiving the excess doses to be able to receive the second dose of the vaccine in due course.
COVID-19 and 2021 influenza vaccines: The how, what, why and when 
This webinar was held on 31 March 2021 as part of the 2021 National Centre for Immunisation Research and Surveillance (NCIRS) COVID-19 vaccine webinar series.
View the video of this webinar to:
  • learn about the 2021 influenza vaccination program, including suggested relative timing for administration of influenza vaccine with COVID-19 vaccine
  • hear an update on the roll-out of COVID-19 vaccines in Australia.
You can view the webinar here
Upcoming webinar: COVID-19 vaccine uptake and acceptance 
The next webinar in the 2021 National Centre for Immunisation Research and Surveillance (NCIRS) COVID-19 vaccine webinar series will be focusing on practical advice for improving COVID-19 vaccine uptake and acceptance.
Date: Friday 30 April 2021
Time: 10:30 pm – 11:30 pm WST
In this webinar:
  • hear an update on COVID-19 vaccine uptake in Australia
  • hear the latest research on Australian attitudes towards COVID-19 vaccines
  • learn evidence-based strategies for increasing COVID-19 vaccine acceptance among your patients, colleagues, family and friends.

Register here
COVID-19 vaccine safety surveillance
The national roll-out of COVID-19 vaccines commenced on 22 February 2021, and AusVaxSafety is conducting active vaccine safety surveillance of the vaccines in use. The vaccines currently being supplied are Comirnaty BNT162b2 (mRNA), sponsored by Pfizer Australia Pty Ltd, and COVID-19 Vaccine AstraZeneca, sponsored by AstraZeneca.
Surveillance data have been provided by Vaxtracker and SmartVax based on surveys sent on Day 3 after the vaccination, and data presented here are from surveys received up to 11 April 2021. These data are updated weekly. 

AusVaxSafety active vaccine safety surveillance system complements the Therapeutic Goods Administration (TGA) enhanced safety surveillance activities. View the TGA COVID-19 vaccine weekly safety report here. Find out more about how the TGA monitors the safety of COVID-19 vaccines and how you can report side effects on the TGA website



Increase in Cold Chain Breaches reported

Please be aware that there have recently been a number of cold chain breaches reported in the Perth metro area. These have been due to a number of issues including power outages, fridge failures and overstocking of fridges (often due to large amounts of flu vaccinations being received).

 Please ensure that your practice staff are aware of the importance of vaccine storage management, are familiar with your vaccine management protocol and of the ‘Strive for 5’ National Vaccine Storage Guidelines.
Please refer to the National Vaccine Storage Guidelines ‘Strive for 5’ for information and advice for vaccine storage management for Australian immunisation service providers.




Conveniently access the AIR through My Health Record

My Health Record allows GPs and practice nurses to easily check immunisation history through the Australian Immunisation
Register (AIR).

If your practice is registered for My Health Record you can view the date of your patients’ immunisation as well other key
information stored within their Australian immunisation history.

The Practice Assist quick reference guide How to access AIR through My Health Record and find a patient’s immunisation
demonstrates how to find your patients’ AIR information in both Best Practice and Medical Director.

If you require support for a different type of clinical software, please email the WA Primary Health Alliance Digital Health team via for support or visit the My Health Record website



2021 Influenza Vaccine Orders Update

WA Primary Health Alliance and WA Health would like to thank all providers for their cooperation regarding the pre-allocation period, and the process has worked well to provide equitable and predictable access to government-funded influenza vaccines for persons aged 65 years and over.

To allow practices to have more flexibility, practices are now able to order influenza vaccines through the standard WA Health vaccine ordering system.

Please be aware, quantity limits will continue to apply to ensure equitable access to all providers, and while all vaccine products continue to arrive at the WA warehouse.

For Further information see Information for GPs regarding pre-allocation and vaccine ordering, visit the Practice Assist 2021 Flu Vaccination Program page or contact



2021 seasonal influenza vaccines - eligibility through the National Immunisation Program (NIP)

This new resource from the Department of Health outlines the eligibility requirements for obtaining National Immunisation Program-funded influenza vaccines in 2021. Groups funded under the program include pregnant women, people with cardiac disease and people with chronic respiratory conditions.

The resource can be viewed here.



WA Primary Health Alliance's GP Innovation Grants

$1,500 grants for IT equipment. Don’t miss out, apply now.

Would you like to enhance your practice’s digital capability with new information technology (IT) equipment to take part in virtual programs, such as telehealth video consultations, webinars, online meetings and more?
To support general practices across Western Australia, WA Primary Health Alliance (WAPHA) is providing GP Innovation
Grants of up to $1,500 per practice, including GST. for the purchase of information technology (IT) equipment to participate
in virtual programs.

Don’t miss this one-time-only opportunity to take advantage of WAPHA’s GP Innovation Grants, which are being allocated
on a first-come-first-served basis.
To apply for a grant, log in to the WAPHA portal and submit the online application form by the closing date of Friday 23
April 2021. If required, email Practice Assist for log in details.

For more information about WAPHA’s GP Innovation Grants and the online application process, view the fact shee​t, email Practice Assist or call 1800 2 ASSIST (1800 2 277 478).

Please note: WAPHA’s GP Innovation Grants are designed to assist general practices with limited digital capability. As a result, corporate practices or legal entities with multiple practices can only apply for a grant for a maximum of four of their practices. Corporate practices and these legal entities should contact their head office before they apply for a grant



NPS MedicineWise Professional Education Virtual Visits

NPS MedicineWise accredited, evidence-based education and professional development topics for GPs are available to be delivered virtually by video call.

Sessions are free and can be delivered in 30mins at a time that suits you.

Bookings can be made via the NPS website.  We can provide a video link, simple instructions and phone support for practices who haven’t tried video calls before.
For further information please visit the NPS Medicine Professional Education website here.



Voluntary Assisted Dying - Update

From 1 July 2021, Western Australians will have access to the Western Australian Voluntary Assisted Dying Statewide Pharmacy Service and the Western Australian Voluntary Assisted Dying Statewide Care Navigator Service. 

Western Australian Voluntary Assisted Dying Statewide Pharmacy Service

The Western Australian Voluntary Assisted Dying Statewide Pharmacy Service (SWPS) has been established to ensure the voluntary assisted dying substance is provided in a safe, equitable, and patient-centred manner. The SWPS continue preparations for operationalisation of this service for 1 July 2021. An information sheet on the SWPS is available here and more information will be made available prior to 1 July 2021.

Western Australian Voluntary Assisted Dying Statewide Care Navigator Service

The Western Australian Voluntary Assisted Dying Statewide Care Navigator Service (SWCNS) has been established to support anyone involved with voluntary assisted dying in WA. Preparations continue in the lead up to 1 July 2021 including the recent appointment of the SWCNS Clinical Nurse Consultant. Recruitment of the Care Navigators is also nearing completion. An information sheet on the SWCNS is available here and more information will be made available prior to 1 July 2021.

Information resources now available

In February several resources were released and can be accessed on the WA Health voluntary assisted dying website.

Voluntary Assisted Dying Implementation Conference

An implementation conference for Western Australian health professionals will be held on Saturday the 22 and Sunday the 23 of May 2021. To register your attendance for the conference, please click here.



MH Connext Program

The MH Connext program helps connect patients who are experiencing severe and complex mental health issues to the right mental health care at the right time.
It is a recovery-oriented program provided in the community by experienced mental health practitioners.
The mental health practitioner works together with the patients GP to provide emotional and psychological help and connect patients with local support services to actively encourage a recovery journey.
For more information on this service please view the patient flyer here or patient brochure here.



The RACGP has published a Resource Guide that contains supplementary information to the 5th Standards. It is intended to assist practices meet the Indicators in the 5th edition.



A feasibility trial of stratified Cognitive Functional Therapy for high risk neck and back injuries following road traffic crash [Whiplash Trial]

This clinical trial is testing an integrated model of care involving physiotherapy, psychology and GP care, looking at how to help people with neck or back pain after a motor vehicle accident.  The research team from Curtin University, University of Queensland, and University of Sydney have provided information for GPs who may have eligible and interested patients experiencing neck or back pain from a recent (< 3 months ago) motor vehicle accident. Please view the Recruitment Information for GPs flyer for more information, and further patient information is available through the trial website Participation is funded by ICWA and is therefore free for patients.



General practice management of patients following acute exacerbations of COPD: an Australian survey (Monash University)

Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.
Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. GPs are invited to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients.
The survey can be accessed by clicking here.



Australian primary care clinicians needed for telehealth research study

Researchers from The University of Queensland, Centre for Online Health, are recruiting clinicians (general practitioners, nurse practitioners, and other allied health staff) to participate in a research study on telehealth use in primary care. For further information please view the flyer here.



Extension of Telehealth Services & HealthDirect Video Call System

The Australian Government announced that it will extend support for telehealth services and care, along with MBS-subsidised telehealth to 30 June 2021.
Along with this announcement, we are also pleased to announce the extension of the healthdirect Video Call COVID-19 GP Program to 31 December 2021. This provides free Video Call access for general practitioners working in private practice and/or Aboriginal Community Controlled Health Organisations (ACCHOs).

  • The Department of Health has extended the healthdirect Video Call COVID-19 GP Program to 31 December 2021.
  • For GPs in private practice wanting to start using the service, please register your practice. For GPs in ACCHOs wanting to start using the service, please register for access.
  • RACGP CPD accredited training in healthdirect Video Call is now available for your practice

RACGP Accredited Training

In collaboration with the RACGP, healthdirect is offering CPD courses that support GPs and Practice Managers to use Video Call more confidently and effectively. The following free courses are run by healthdirect RACGP Education Activity Representatives:
  • Essential Video Call training 1 hour 2 CPD points for RACGP or 1-hour ACCRM credit
This module is for GPs new to Video Call and covers the basic functionality of the platform. The course will also suit Practice Managers who may be implementing telehealth into their practice workflows. Register here for essential training
  • Advanced Video Call training 1 hour 2 CPD points for RACGP or 1-hour ACCRM credit

This module covers more advanced use of the platform. The course will also suit Practice Managers and anyone interested in how Video Call can reshape the provision of services to patients or clients. Register here for advanced training
For further information, or to register for access to the platform, please contact the healthdirect Video Call team or the WAPHA Digital Health Team




Wellbeing support at hand during stressful times for WA general practice teams

Professional and personal pressures can arise for general practice teams at the best of times, let alone during a global pandemic.
To support GPs and practice staff to look after themselves and take the necessary steps to support their wellbeing, WA Primary Health Alliance is offering three free confidential counselling sessions via its Wellness Program.
Provided through AccessEAP, and available to all WA-based general practice staff, the program offers confidential sessions with a counsellor who can offer information and assistance in navigating the COVID-19 response as well as other personal and professional issues.

Issues that can be addressed during counselling sessions include:EAP.png

  • Preparing for major life changes
  • Changes at work
  • Changes within family (marriage, new baby, divorce/separation)
  • Goal setting for professional or personal life
  • Developing new strategies for handling stress at work or at home
  • Or simply to have someone to speak to about any of life’s inevitable challenges

To book a confidential phone or video counselling appointment, you can call AccessEAP anytime on 1800 818 728.

You will need to identify as a WA Primary Health Alliance member.


GPs and practice staff can also contact Practice Assist by calling 1800 2 ASSIST or emailing with any questions about the program.
For more information please visit the Practice Assist COVID-19 Well-being and Support webpage.





Health Promotion Events

Heart Week is 3 to 9 May – With your help we can make an IMPACT

Heart Week is coming soon, 3 – 9 May 2021! This year, the Heart Foundation is calling on health professionals to start a conversation with their patients about the importance of heart health and routine Heart Health Checks.

Start opportunistic conversations

Make the most out of your vaccination appointments and use the opportunity for increased patient contact to book eligible patients in for a Heart Health Check and other important preventative checks. Access our Heart Week promotional pack to start the conversation.

Use our new Heart Health Check Toolkit

Use templates and resources from our new Heart Health Check Toolkit to help streamline your delivery of Heart Health Checks and kickstart quality improvement activities. Browse the Toolkit here.

Join the free Heart Week Webinar

This Heart Week, join international and local CVD experts for an engaging discussion on the latest evidence for CVD prevention in primary care, including an update on coronary artery calcium scoring. Save your spot for the webinar today.

Further resources for your practice

Coming up soon......

World Immunisation Week April 24-30
World Malaria Day April 25
Art for Epilepsy May 1-31
Crohn's & Colitis Awareness Week May 1-31
Tourette Syndrome Awareness Week May 5-11
World Asthma Day May 5



Practice Assist Resource Library

As part of our support for general practices, Practice Assist maintains a library of useful resources in our Practice Assist Resource Library. These resources range across different topics from GP Accreditation, Practice Incentives Program, to the latest in resources around COVID-19.
Here are some of our new and updated resources:

Clinical Resources

COVID-19 Resources

Digital Health


Nurses in General Practice

Programs and National Schemes

Nurses in General Practice

General Practice Accreditation

If you have an idea for a new resource or feedback on our current resources, please email with ideas and comments.



Allocation of surgical masks from the National Medical Stockpile

WA Primary Health Alliance continues to operate a significant logistical strategy to distribute masks during the COVID-19 pandemic to general practices, Aboriginal Community Controlled Health Organisations, pharmacies and allied health practices that meet the criteria of the Department of Health Tranche 4 guidelines.
For mask requests, visit the Practice Assist website. Please note, re-orders will not be accepted within five business days (Mon-Fri) of the previous request, except in exceptional circumstances.
Please send all general queries in relation to the National Medical Stockpile to



Education and training

Visit our Webinars & Workshops page at for the events calendar.


Learn how to assess and manage concussion
Presented by Australasian College of Sport & Exercise Physicians
Multiple dates March to June 2021



Cervical Screening for nurses
Presented by Sexual Head Quarters (SHQ)
Multiple dates
Hear No, Smell No, Speak No: Paediatric ENT Update
Presented by FSH and Health Pathways
Thursday 22 April
Automated coaching programs to improve diabetes management
Presented by Connected Health CRE

Thursday 22 April
North Metro Foot Initiative Dinner
Presented by Diabetes WA
Thursday 22 April
Course in Ear and Hearing Health
Presented by The Benchmarque Group
Monday 19, Tuesday 20 & Wednesday 21 April
Course in Ear Canal Microsuction
Presented by The Benchmarque Group
Thursday 22 & Friday 23 April
Midwest-Gascoyne Health Professionals Network Launch
Presented by Midwest-Gascoyne Health Professionals Network
Thursday 22 April
With the end in mind: Palliative care and voluntary assisted dying
Presented by Cancer Council WA
Wednesday 28 April
COVID-19 vaccine uptake and acceptance
Presented by NCIRS
Friday 30 April
Pathfinder: Early Career GP Conference 2021
Presented by RACGP
Saturday 1 May
Neurological Emergencies Workshop
Presented by Rural Health West
Friday 7 May
Certificate in Sexual and Reproductive Health (Nursing)
Presented by Sexual Head Quarters (SHQ)
Monday 10 to Thursday 13 May
Contraceptive Implant training for Nurses
Presented by Sexual Head Quarters (SHQ)
Thursday 13 May
Paediatric Emergencies and Clinical Healthcare Scenarios (PEaCHS)
Presented by Rural Health West
Friday 21 May
Toxicological Emergencies
Presented by Rural Health West
Friday 21 May
Rural Remote Retrieval Weekend 2021
Presented by Rural Health West
Thursday 13 to Sunday 16 May
Voluntary Assisted Dying Implementation Conference
Presented by WA Department of Health
Saturday 22 and Sunday 23 May 2021
Obstetric Emergencies
Presented by Rural Health West
Friday 11 June
Rural Anaesthesia Down Under Conference 2021
Presented by Rural Health West
Sunday 13 to Wednesday 16 June
Rural Obstetric and Gynaecology Forum 2021
Presented by Rural Health West
Friday 18 to Sunday 20 June
2021 Wound Management Workshops: Rural
Presented by Clinical Design Solutions
Multiple dates (rural WA)
Joint Australasian Sexual Health and HIV&AIDS Conferences: VIRTUAL
Presented by ASHM
Monday 6 to Thursday 9 September


Online Training

Foundations of Spirometry in Primary Health Care Presented by APNA
GP Framework for Child Mental Health Assessment Presented by Emerging Minds
Diabetes in Practice for Nurses Presented by Diabetes Qualified
COVID-19 Infection Control Training Presented by Department of Health
Chronic Disease Mgmt Healthy Ageing Program Presented by APNA
Electronic Prescribing online training Presented by ADHA
Practice Assist acknowledges and pays respect to the Traditional Owners and Elders of this country and recognises the significant importance of their cultural heritage, values and beliefs and how these contribute to the positive health and wellbeing of the whole community.

While the Australian Government Department of Health has contributed to the funding of this website, the information on this website does not necessarily reflect the views of the Australian Government and is not advice that is provided, or information that is endorsed, by the Australian Government. The Australian Government is not responsible in negligence or otherwise for any injury, loss or damage however arising from the use of or reliance on the information provided on this website.